"To evaluate the efficacy of Madhuyashti Granules and Shirodhara in the management of Attention Deficit Hyperactivity Disorder (ADHD) in school going children."

"A clinical study to evaluate the efficacy of Madhuyashti Granules and Shirodhara in the management of Attention Deficit Hyperactivity Disorder (ADHD) in school going children."

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/052151

Enrollment

Registered

2023-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individual between age group of 6 to 15 years of both genders having fulfilled DSM V criteria. 2. Children with IQ > 80. 3. Parents of patient willing to participate in the trial.

Exclusion criteria

Exclusion criteria: 1. Individuals below 6 years & above 15 years of age. 2. Mental disorders like conduct disorder, anxiety, depressive disorders, obsessive disorders & compulsive disorder. 3. Children with schizophrenia. 4. Children having medical illness like hearing loss, hypothyroidism, genetic disorder & seizures. 5. Children having congenital deformity or Muscular dystrophy.

Design outcomes

Primary

Measure	Time frame
Fulfillment of objective criteria.Timepoint: 45 days	—

Secondary

Measure	Time frame
To find out the prevalence of ADHD.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Zenia Dharani

RGGPG Ayurvedic College and Hospital

drminakshi2050@gmail.com9418017565

Outcome results